Abstract
Purpose of Review
Septic bursitis is a relatively common condition that causes substantial morbidity, but there is no universally accepted approach to management. We aim to evaluate recent literature with an eye toward recommended changes in the practice of bursal aspiration, surgical debridement, and antibiotic treatment.
Recent Findings
Authors of recent studies suggest that most patients with uncomplicated septic bursitis can be treated nonoperatively, perhaps even without aspiration of the bursal sac, and can achieve satisfactory clinical response with antibiotics alone. Surgical debridement has not been shown to be superior to nonoperative approaches but is recommended for complex or refractory cases. Optimal antibiotic route and duration is largely determined by severity of the presentation, but many authors favor transition to oral antibiotic therapy early where appropriate.
Summary
There remains considerable heterogeneity regarding the best management of septic bursitis, ranging from aggressive surgical debridement to isolated antibiotic treatment. Bursal aspiration can help to guide antimicrobial therapy but is not necessarily a requirement in making the diagnosis if patients show an adequate response to empiric antibiotics. Close follow-up after initial presentation for patients with proven or suspected septic bursitis is important to determine their clinical response and to further guide their management.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Availability of Data and Materials
Not applicable.
References
Papers of particular interest, published recently, have been highlighted as: • Of Importance
McAfee JH, Smith DL. Olecranon and prepatellar bursitis. Diagnosis and treatment. West J Med. 1988 Nov;149(5):607–10. PMID: 3074561; PMCID: PMC1026560.
McCarthy P. Managing Bursitis in the Athlete: An Overview. Phys Sportsmed. 1989;17(11):115–25. https://doi.org/10.1080/00913847.1989.11709916.
Reid CR, Bush PM, Cummings NH, McMullin DL, Durrani SK. A review of occupational knee disorders. J Occup Rehabil. 2010;20(4):489–501. https://doi.org/10.1007/s10926-010-9242-8.
Zimmermann B 3rd, Mikolich DJ, Ho G Jr. Septic bursitis. Semin Arthritis Rheum. 1995;24(6):391–410. https://doi.org/10.1016/s0049-0172(95)80008-5.
Baumbach SF, Lobo CM, Badyine I, Mutschler W, Kanz KG. Prepatellar and olecranon bursitis: literature review and development of a treatment algorithm. Arch Orthop Trauma Surg. 2014;134(3):359–70. https://doi.org/10.1007/s00402-013-1882-7.
Lieber SB, Fowler ML, Zhu C, Moore A, Shmerling RH, Paz Z. Clinical characteristics and outcomes of septic bursitis. Infection. 2017;45(6):781–6. Epub 20170529. https://doi.org/10.1007/s15010-017-1030-3.
Reilly D, Kamineni S. Olecranon bursitis. J Shoulder Elbow Surg. 2016 Jan;25(1):158–67. Epub 20151111. https://doi.org/10.1016/j.jse.2015.08.032.
Small LN, Ross JJ. Suppurative tenosynovitis and septic bursitis. Infect Dis Clin N Am. 2005;19:991–1005. https://doi.org/10.1016/j.idc.2005.08.002.
• Charret L, Bart G, Hoppe E, Dernis E, Cormier G, Boutoille D, Le Goff B, Darrieutort-Laffite C. Clinical characteristics and management of olecranon and prepatellar septic bursitis in a multicentre study. J Antimicrob Chemother. 2021;76(11):3029–32. https://doi.org/10.1093/jac/dkab265. This study included a large cohort of septic bursitis patients with evaluation of surgical and antibiotic management strategies.
Cea-Pereiro JC, Garcia-Meijide J, Mera-Varela A, Gomez-Reino JJ. A comparison between septic bursitis caused by Staphylococcus aureus and those caused by other organisms. Clin Rheumatol. 2001;20(1):10–4. https://doi.org/10.1007/s100670170096.
Söderquist B, Hedström SA. Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis. Scand J Infect Dis. 1986;18(4):305–11. https://doi.org/10.3109/00365548609032341.
Ho G Jr, Tice AD, Kaplan SR. Septic bursitis in the prepatellar and olecranon bursae: an analysis of 25 cases. Ann Intern Med. 1978;89(1):21–7. https://doi.org/10.7326/0003-4819-89-1-21.
Glass M, Everist B, Nelson D, Spencer J. Methicillin-resistant Staphylococcal aureus patellar tendon abscess and septic prepatellar bursitis in an injection drug user. Radiol Case Rep. 2018;14(2):238–41. https://doi.org/10.1016/j.radcr.2018.10.036.
Lormeau C, Cormier G, Sigaux J, Arvieux C, Semerano L. Management of septic bursitis. Joint Bone Spine. 2019;86(5):583–8. https://doi.org/10.1016/j.jbspin.2018.10.006.
Skedros JG, Finlinson ED, Luczak MG, Cronin JT. Septic olecranon bursitis with osteomyelitis attributed to Cutibacterium acnes: case report and literature: overview of the dilemma of potential contaminants and false-positives. Cureus. 2023;15(2):e34563. https://doi.org/10.7759/cureus.34563.
Esmaeilnejad-Ganji SM, Esmaeilnejad-Ganji SMR. Osteoarticular manifestations of human brucellosis: a review. World J Orthop. 2019;10(2):54–62. https://doi.org/10.5312/wjo.v10.i2.54.
Katwilat P, Chongtrakool P, Muangsomboon S, Jitmuang A. Prototheca wickerhamii prepatellar bursitis in an immunocompetent woman: a case report. J Mycol Med. 2019;29(4):361–4. https://doi.org/10.1016/j.mycmed.2019.100901.
Nguyen K, Coquerelle P, Houvenagel E, Ducoulombier V, Senneville E, Cortet B, et al. Characteristics and management of olecranon or prepatellar septic bursitis. Infect Dis Now. 2023;53(2):104652. https://doi.org/10.1016/j.idnow.2023.104652.
Blankstein A, Ganel A, Givon U, Mirovski Y, Chechick A. Ultrasonographic findings in patients with olecranon bursitis. Ultraschall Med. 2006;27(6):568–71. https://doi.org/10.1055/s-2006-926569.
Khodaee M. Common superficial bursitis. Am Fam Physician. 2017;95(4):224–31 PMID: 28290630.
Stell IM, Gransden WR. Simple tests for septic bursitis: comparative study. BMJ. 1998;316(7148):1877. https://doi.org/10.1136/bmj.316.7148.1877.
Perez C, Huttner A, Assal M, Bernard L, Lew D, Hoffmeyer P, Uçkay I. Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients. J Antimicrob Chemother. 2010;65(5):1008–14. https://doi.org/10.1093/jac/dkq043.
O'Shea NE, Tadi P. Olecranon Bursa aspiration. [Updated 2023 Jul 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK554617/.
Deal JB Jr, Vaslow AS, Bickley RJ, Verwiebe EG, Ryan PM. Empirical treatment of uncomplicated septic olecranon bursitis without aspiration. J Hand Surg Am. 2020;45(1):20–5. https://doi.org/10.1016/j.jhsa.2019.06.012.
• Beyde A, Thomas AL, Colbenson KM, Sandefur BJ, Kisirwan I, Mullan AF, et al. Efficacy of empiric antibiotic management of septic olecranon bursitis without bursal aspiration in emergency department patients. Acad Emerg Med. 2022;29(1):6–14. Epub 20211109. https://doi.org/10.1111/acem.14406. This is a larger cohort study evaluating outcomes with non-surgical management for septic bursitis.
Thomas AL, Beyde A, Sandefur BJ, Colbenson KM, Kisirwan I, Finley AL, Mullan AF, Krych AJ, Campbell RL. Efficacy of empiric antibiotic therapy without aspiration for septic prepatellar bursitis in emergency department patients. Acad Emerg Med. 2022;29(8):1027–32. https://doi.org/10.1111/acem.14499.
• Brown OS, Smith TO, Parsons T, Benjamin M, Hing CB. Management of septic and aseptic prepatellar bursitis: a systematic review. Arch Orthop Trauma Surg. 2022;142(10):2445–57. https://doi.org/10.1007/s00402-021-03853-9. This is a contemporary, large systematic review of outcomes and management of septic bursitis.
Ho G Jr, Su EY. Antibiotic therapy of septic bursitis. Its implication in the treatment of septic arthritis. Arthritis Rheum. 1981 Jul;24(7):905–11. https://doi.org/10.1002/art.1780240707.
Uçkay I, von Dach E, Perez C, Agostinho A, Garnerin P, Lipsky BA, et al. One- vs 2-stage bursectomy for septic olecranon and prepatellar bursitis: a prospective randomized trial. Mayo Clin Proc. 2017;92(7):1061–9. https://doi.org/10.1016/j.mayocp.2017.03.011.
Meade TC, Briones MS, Fosnaugh AW, Daily JM. Surgical outcomes in endoscopic versus open bursectomy of the septic prepatellar or olecranon bursa. Orthopedics. 2019;42(4):e381–4. https://doi.org/10.3928/01477447-20190321-04.
Author information
Authors and Affiliations
Contributions
RW and MB performed the literature search and data analysis and drafted the manuscript. WA performed a literature search and critically revised the work. All authors reviewed and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical Approval
Not applicable.
Conflict of Interest
All authors have no conflicts of interest to disclose.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Weihe, R., Birt, M.C. & Atrouni, W.E. Should We Tap That? Aspirates and Antibiotics: An Update on Septic Bursitis. Curr Infect Dis Rep 25, 331–335 (2023). https://doi.org/10.1007/s11908-023-00819-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11908-023-00819-3